New perspectives in improving prognosis after myocardial infarction
The results of large, epidemiologic studies and clinical trials, e.g., GISSI-Prevenzione, demonstrate that highly purified omega-3 polyunsaturated fatty acids should be included into secondary prevention among myocardial infarction patients. Their positive clinical effects include: all-cause mortali...
Main Author: | N. M. Akhmedzhanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1206 |
Similar Items
-
ω3-polyunsarturated fatty acid medications in cardiovascular event prevention
by: K. A. Talitsky, et al.
Published: (2006-12-01) -
PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
by: V. P. Mikhin, et al.
Published: (2017-12-01) -
Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year
by: N. G. Gogolashvili, et al.
Published: (2011-10-01) -
FREQUENCY OF OCCURRENCE OF RISK FACTORS AND ADHERENCE TO DRUG THERAPY IN YAKUTS WHO UNDERWENT Q-POSITIVE MYOCARDIAL INFARCTION
by: E. S. Kylbanova, et al.
Published: (2018-08-01) -
Secondary prevention of myocardial infarction: effectiveness assessment in primary healthcare settings
by: Yu. I. Nesterov, et al.
Published: (2010-10-01)